Mikhail K. Devkota
Moscow, MOW 127006, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Study on the efficacy of combination therapy with rifaximin and Saccharomyces boulardii CNCM I-745 in patients with small intestinal bacterial overgrowth associated with long-term use of proton pump inhibitors
Journal: Terapevticheskii arkhiv
Published: April 23, 2025
Gut Mycobiome Changes During COVID-19 Disease.
Journal: Journal of fungi (Basel, Switzerland)
Published: January 09, 2025
Microbial Signatures in COVID-19: Distinguishing Mild and Severe Disease via Gut Microbiota.
Journal: Biomedicines
Published: April 14, 2024
Study of the resistome of human microbial communities using a targeted panel of antibiotic resistance genes in COVID-19 patients
Journal: Terapevticheskii arkhiv
Published: January 31, 2024
Evaluation of serum and urine biomarkers for severe COVID-19.
Journal: Frontiers in medicine
Published: December 18, 2023
Efficacy of Saccharomyces boulardii CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19
Journal: Terapevticheskii arkhiv
Published: November 22, 2022
Composition of oropharyngeal microbiota in patients with COVID-19 of different pneumonia severity
Journal: Terapevticheskii arkhiv
Published: October 11, 2022
Prevalence and prognostic value of gastroenterological manifestations of COVID-19: data from the Russian University Clinic
Journal: Terapevticheskii arkhiv
Published: August 15, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026